Basics ADC Therapeutics SA IPO Date: May 18, 2020 Sector: Healthcare Industry: Biotech Market Cap: $398.25M Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 3.84% Avg Daily Range (30 D): $0.08 | 2.78% Avg Daily Range (90 D): $0.12 | 4.36% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): .59M Avg Daily Volume (90 D): .64M Trade Size Avg Trade Size (Sh.): 140 Avg Trade Size (Sh.) (30 D): 137 Avg Trade Size (Sh.) (90 D): 153 Institutional Trades Total Inst.Trades: 299 Avg Inst. Trade: $1.35M Avg Inst. Trade (30 D): $1.16M Avg Inst. Trade (90 D): $1.39M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.38M Avg Closing Trade (30 D): $2.08M Avg Closing Trade (90 D): $2.08M Avg Closing Volume: 515K     News Jun 26, 2025 @ 3:44 PM The $900 Billion Question: Who Will Deliver the Ne... Source: Prnewswire May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Oct 31, 2024 @ 4:57 PM Cancer Antibody Drug Conjugates Market, Drugs Appr... Source: Researchandmarkets.Com Aug 6, 2024 @ 10:51 PM ADC Therapeutics berichtet über Finanzergebniss... Source: Adc Therapeutics Jul 12, 2024 @ 10:40 AM Antibody Drug Conjugates Market Insights 2018-2023... Source: Researchandmarkets.Com Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.55 $-.5 $-.36 Diluted EPS $-1.55 $-.5 $-.36 Revenue $ 77.25M $ 18.84M $ 23.03M Gross Profit $ $ $ Net Income / Loss $ -169.94M $ -56.65M $ -38.6M Operating Income / Loss $ -140.61M $ -44.15M $ -28.46M Cost of Revenue $ $ $ Net Cash Flow $ -35.56M $ 69.86M $ -56.17M PE Ratio     Splits May 10, 2005:   1:7